术前常规影像学阴性的前列腺癌淋巴结阳性患者术后辅助放疗或有无早期补救性放疗的观察:一项多中心研究

IF 5.9 2区 医学 Q1 UROLOGY & NEPHROLOGY
Journal of Urology Pub Date : 2025-06-01 Epub Date: 2025-02-10 DOI:10.1097/JU.0000000000004468
Giancarlo Marra, Francesco Barletta, Simone Scuderi, Gabriele Montefusco, Jonathan Olivier, Andres Affentranger, Josias Bastian Grogg, Thomas Hermanns, Luca Afferi, Christian Fankhauser, Agostino Mattei, Bartosz Malkiewicz, Alberto Bianchi, Alessandro Antonelli, Fabio Zattoni, Fabrizio Dal Moro, Lieke Wever, Timo F W Soeterik, Roderick C N Van Den Bergh, Pawel Rajwa, Shahrokh F Shariat, Rafael Sanchez-Salas, Lara Rodriguez-Sanchez, Rossella Nicoletti, Riccardo Campi, Mohamed Ahmed, R Jeffrey Karnes, Isabel Heidegger, Alberto Briganti, Francesco Montorsi, Paolo Gontero, Giorgio Gandaglia
{"title":"术前常规影像学阴性的前列腺癌淋巴结阳性患者术后辅助放疗或有无早期补救性放疗的观察:一项多中心研究","authors":"Giancarlo Marra, Francesco Barletta, Simone Scuderi, Gabriele Montefusco, Jonathan Olivier, Andres Affentranger, Josias Bastian Grogg, Thomas Hermanns, Luca Afferi, Christian Fankhauser, Agostino Mattei, Bartosz Malkiewicz, Alberto Bianchi, Alessandro Antonelli, Fabio Zattoni, Fabrizio Dal Moro, Lieke Wever, Timo F W Soeterik, Roderick C N Van Den Bergh, Pawel Rajwa, Shahrokh F Shariat, Rafael Sanchez-Salas, Lara Rodriguez-Sanchez, Rossella Nicoletti, Riccardo Campi, Mohamed Ahmed, R Jeffrey Karnes, Isabel Heidegger, Alberto Briganti, Francesco Montorsi, Paolo Gontero, Giorgio Gandaglia","doi":"10.1097/JU.0000000000004468","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Our goals were to assess the survival outcomes of adjuvant radiation therapy (aRT) vs observation with or without early salvage radiation therapy for cN0M0 pN1 prostate cancer (PCa) and to create a model for clinical decision-making.</p><p><strong>Materials and methods: </strong>We retrospectively identified 1103 patients with cN0M0 PCa with pN1 PCa after surgery (2000-2021) at 18 referral centers. Kaplan-Meier curves and Cox proportional hazards models were used.</p><p><strong>Results: </strong>Overall, 670 patients (61%) had International Society of Urological Pathology (ISUP) 4 to 5, and the median number of positive nodes was 1. On multivariable analyses, ≥ 3 positive nodes (HR, 2.03, 95% CI, 1.22-3.37; <i>P</i> = .006) and ISUP 5 (HR, 1.92, 95% CI, 1.15-3.18; <i>P</i> = .01) were associated with an increased all-cause mortality. Based on pT stage, ISUP, and positive nodes, a 2 risk categories model was created. In men undergoing observation, 7-year disease-free survival was 27% (95% CI, 20.4-36) for low- to intermediate-risk and 11% (95% CI, 6.7-17) for high-risk patients; aRT had higher overall survival rates in the high-risk group (92%; 95% CI, 87-96 vs observation 84%, 95% CI, 77-90; <i>P</i> = .006). In interaction term analyses, aRT confirmed its protective effect on mortality in high-risk patients (HR, 0.28, 95% CI, 0.09-0.84, <i>P</i> = .024). Results were comparable when excluding men with PSA persistence.</p><p><strong>Conclusions: </strong>In cN0M0 pN+ PCa, aRT yields a survival benefit compared with observation with or without early salvage radiation therapy only in men with a high-risk disease based on unfavorable prognostic factors. We created a risk model to guide clinical decision-making in this setting.</p>","PeriodicalId":17471,"journal":{"name":"Journal of Urology","volume":" ","pages":"702-712"},"PeriodicalIF":5.9000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Adjuvant Radiation Therapy or Observation With or Without Early Salvage Radiation Therapy for Men With Node-Positive Prostate Cancer After Surgery and Negative Preoperative Conventional Imaging: A Multicenter Study.\",\"authors\":\"Giancarlo Marra, Francesco Barletta, Simone Scuderi, Gabriele Montefusco, Jonathan Olivier, Andres Affentranger, Josias Bastian Grogg, Thomas Hermanns, Luca Afferi, Christian Fankhauser, Agostino Mattei, Bartosz Malkiewicz, Alberto Bianchi, Alessandro Antonelli, Fabio Zattoni, Fabrizio Dal Moro, Lieke Wever, Timo F W Soeterik, Roderick C N Van Den Bergh, Pawel Rajwa, Shahrokh F Shariat, Rafael Sanchez-Salas, Lara Rodriguez-Sanchez, Rossella Nicoletti, Riccardo Campi, Mohamed Ahmed, R Jeffrey Karnes, Isabel Heidegger, Alberto Briganti, Francesco Montorsi, Paolo Gontero, Giorgio Gandaglia\",\"doi\":\"10.1097/JU.0000000000004468\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Our goals were to assess the survival outcomes of adjuvant radiation therapy (aRT) vs observation with or without early salvage radiation therapy for cN0M0 pN1 prostate cancer (PCa) and to create a model for clinical decision-making.</p><p><strong>Materials and methods: </strong>We retrospectively identified 1103 patients with cN0M0 PCa with pN1 PCa after surgery (2000-2021) at 18 referral centers. Kaplan-Meier curves and Cox proportional hazards models were used.</p><p><strong>Results: </strong>Overall, 670 patients (61%) had International Society of Urological Pathology (ISUP) 4 to 5, and the median number of positive nodes was 1. On multivariable analyses, ≥ 3 positive nodes (HR, 2.03, 95% CI, 1.22-3.37; <i>P</i> = .006) and ISUP 5 (HR, 1.92, 95% CI, 1.15-3.18; <i>P</i> = .01) were associated with an increased all-cause mortality. Based on pT stage, ISUP, and positive nodes, a 2 risk categories model was created. In men undergoing observation, 7-year disease-free survival was 27% (95% CI, 20.4-36) for low- to intermediate-risk and 11% (95% CI, 6.7-17) for high-risk patients; aRT had higher overall survival rates in the high-risk group (92%; 95% CI, 87-96 vs observation 84%, 95% CI, 77-90; <i>P</i> = .006). In interaction term analyses, aRT confirmed its protective effect on mortality in high-risk patients (HR, 0.28, 95% CI, 0.09-0.84, <i>P</i> = .024). Results were comparable when excluding men with PSA persistence.</p><p><strong>Conclusions: </strong>In cN0M0 pN+ PCa, aRT yields a survival benefit compared with observation with or without early salvage radiation therapy only in men with a high-risk disease based on unfavorable prognostic factors. We created a risk model to guide clinical decision-making in this setting.</p>\",\"PeriodicalId\":17471,\"journal\":{\"name\":\"Journal of Urology\",\"volume\":\" \",\"pages\":\"702-712\"},\"PeriodicalIF\":5.9000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Urology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/JU.0000000000004468\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/10 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/JU.0000000000004468","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/10 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:评估辅助放疗(aRT)与早期补救性放疗(Obs±esRT)治疗cN0M0 pN1前列腺癌的生存结果,并为临床决策建立模型。材料和方法:我们回顾性分析了18个转诊中心的1103例cN0M0型PCa合并pN1型PCa术后患者(2000-2021)。采用Kaplan-Meier曲线,Cox比例风险。结果:总体而言,670例(61%)有ISUP 4-5,阳性淋巴结中位数为1。在多变量分析中,≥3个阳性节点(HR 2.03,95% CI 1.22-3.37;p=0.006)和ISUP 5 (HR 1.92,95% CI 1.15-3.18;P =0.01)与全因死亡率增加相关。基于pT分期、ISUP和阳性节点,建立两类风险模型。在接受观察的男性中,中低危患者的7年无病生存率为27% (95%CI 20.4-36),高危患者的7年无病生存率为11% (95%CI 6.7-17);aRT在高危组有更高的OS率(92%;95%CI 87-96 vs观察组84%,95%CI 77-90;p = 0.006)。在相互作用项分析中,aRT证实了其对高危患者死亡率的保护作用(HR 0.28, 95% CI 0.09-0.84, p=0.024)。当排除PSA持续性的男性时,结果具有可比性。结论:在cN0M0 pN+ PCa中,与仅Obs±esRT相比,aRT在基于不利预后因素的高风险疾病男性中获得了生存优势。我们创建了一个风险模型来指导这种情况下的临床决策。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Adjuvant Radiation Therapy or Observation With or Without Early Salvage Radiation Therapy for Men With Node-Positive Prostate Cancer After Surgery and Negative Preoperative Conventional Imaging: A Multicenter Study.

Purpose: Our goals were to assess the survival outcomes of adjuvant radiation therapy (aRT) vs observation with or without early salvage radiation therapy for cN0M0 pN1 prostate cancer (PCa) and to create a model for clinical decision-making.

Materials and methods: We retrospectively identified 1103 patients with cN0M0 PCa with pN1 PCa after surgery (2000-2021) at 18 referral centers. Kaplan-Meier curves and Cox proportional hazards models were used.

Results: Overall, 670 patients (61%) had International Society of Urological Pathology (ISUP) 4 to 5, and the median number of positive nodes was 1. On multivariable analyses, ≥ 3 positive nodes (HR, 2.03, 95% CI, 1.22-3.37; P = .006) and ISUP 5 (HR, 1.92, 95% CI, 1.15-3.18; P = .01) were associated with an increased all-cause mortality. Based on pT stage, ISUP, and positive nodes, a 2 risk categories model was created. In men undergoing observation, 7-year disease-free survival was 27% (95% CI, 20.4-36) for low- to intermediate-risk and 11% (95% CI, 6.7-17) for high-risk patients; aRT had higher overall survival rates in the high-risk group (92%; 95% CI, 87-96 vs observation 84%, 95% CI, 77-90; P = .006). In interaction term analyses, aRT confirmed its protective effect on mortality in high-risk patients (HR, 0.28, 95% CI, 0.09-0.84, P = .024). Results were comparable when excluding men with PSA persistence.

Conclusions: In cN0M0 pN+ PCa, aRT yields a survival benefit compared with observation with or without early salvage radiation therapy only in men with a high-risk disease based on unfavorable prognostic factors. We created a risk model to guide clinical decision-making in this setting.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Urology
Journal of Urology 医学-泌尿学与肾脏学
CiteScore
11.50
自引率
7.60%
发文量
3746
审稿时长
2-3 weeks
期刊介绍: The Official Journal of the American Urological Association (AUA), and the most widely read and highly cited journal in the field, The Journal of Urology® brings solid coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of urology. This premier journal presents investigative studies on critical areas of research and practice, survey articles providing short condensations of the best and most important urology literature worldwide, and practice-oriented reports on significant clinical observations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信